Adaptive Biotechnologies Corporation
USD22.92
+0.82 (+3.71%)
CEO
Chad Robins
IPO Date
2019-06-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.51
Prev. Close
$22.10
Day Low
$21.36
Day High
$23.02
52W Low
$9.96
52W High
$23.15
Market Cap
$3.67B
Volume
3.23M
| 23,677 |
| $12.14 |
| 17 Jul 2026 | LO FRANCIS | Chief People Officer | M-Exempt | Acquired | 22,711 | $8.46 |
| 17 Jul 2026 | LO FRANCIS | Chief People Officer | S-Sale | Disposed | 105,762 | $22.59 |
| 17 Jul 2026 | LO FRANCIS | Chief People Officer | M-Exempt | Disposed | 59,374 | $7.80 |
| 17 Jul 2026 | LO FRANCIS | Chief People Officer | M-Exempt | Disposed | 23,677 | $12.14 |
| 17 Jul 2026 | LO FRANCIS | Chief People Officer | M-Exempt | Disposed | 22,711 | $8.46 |
| 7 Jul 2026 | ROBINS HARLAN S | Chief Scientific Officer | S-Sale | Disposed | 239,351 | $21.74 |
| 7 Jul 2026 | ROBINS HARLAN S | Chief Scientific Officer | S-Sale | Disposed | 146,889 | $22.45 |
| 6 Jul 2026 | LO FRANCIS | Chief People Officer | M-Exempt | Acquired | 3,500 | $7.80 |